THE SAFETY OF SYSTEMIC ANTICANCER TREATMENT IN PATIENTS WITH END-STAGE KIDNEY DISEASE AND METASTATIC RENAL CELL CARCINOMA

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/9ca363a5a84b27bf44ac9334c40347d1.pdf

Abstract Title

First Name *

Tomaz

Last Name *

Milanez

Co-author 1

Miha Arnol miha.arnol@kclj.si University Medical Center Ljubljana Department of Nephrology Ljubljana

Co-author 2

Bostjan Seruga bseruga@onko-i.si Institute of Oncology Ljubljana Devision of Medical Oncology Ljubljana

Co-author 3

Vinay Srinivasan srinivasan-vinay@CooperHealth.edu Cooper University Hospital and Cooper Medical School of Rowan University Camden, New Jersey, USA Division of Nephrology Ljubljana

Co-author 4

Janja Ocvirk jocvirk@onko-i.si Institute of Oncology Ljubljana Devision of Medical Oncology Ljubljana

Co-author 5

Edgar A. Jaimes jaimese@mskcc.org Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medicine, New York,NY Renal Service, Department of Medicine New York

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15